Mediorbis is a Germany-based startup that started as an online platform for doctors but has evolved into a highly technological online publisher for medical content and apps. The company's business model revolves around generating user traffic through its own content on www.mediorbis.de and then monetizing it through self-developed applications, relevant affiliate marketing, and targeted online advertising. With a team of 50 editors from 7 European countries, Mediorbis consistently produces new SEO-optimized content and has already generated over 41,000 organic page views per month as of June 2023. The startup currently boasts around 116 SEO-optimized guides covering approximately 824,340 words in 10 medical topics, with plans to expand to 50 medical topics and around 2,500 digital guides in the near future. Its monthly visitors have increased by an impressive 482% year-over-year, leading to a doubling of company revenue during the same period. Mediorbis's content strategy focuses on a steadily expanding evergreen approach, not only producing medical guides but also creating content for platforms such as LinkedIn, YouTube, and other social media channels. The company is now aiming to significantly expand its content and internationally roll out its product and service portfolios. As a data-driven publisher for freely accessible medical content, IT, and AI applications in Germany, Mediorbis is positioned as a promising player in the health care and information technology industries, showing strong growth potential as it captures a larger audience and expands its content offerings. To potential venture capital investors, Mediorbis presents an opportunity for investment in a technology-driven, content-centric startup with a strong foothold in Germany and ambitious plans for international expansion. With its impressive growth in both traffic and revenue, Mediorbis demonstrates the ability to effectively monetize its user base and capitalize on the growing demand for reliable medical content and applications. You can find more about Mediorbis on their website and healthcare AI platform.
There is no investment information
No recent news or press coverage available for mediorbis.